去甲变肾上腺素和变肾上腺素检测用处理人血浆样本的互换性评估
该研究评估了八种处理人血浆样本用于去甲变肾上腺素和变肾上腺素外部质量评估的互换性,并比较了常规检测方法与候选参考测量程序的一致性。结果表明,高浓度加标混合血浆和加标个体血浆可作为候选外部质量评估材料,常规方法与参考程序的一致性总体满意,但一种常规检测存在显著偏倚。
要点
- 高浓度加标混合血浆和加标个体血浆可作为去甲变肾上腺素和变肾上腺素外部质量评估的候选材料。
- CLSI互换性评估方法的结果优于IFCC方法。
- 常规检测与候选参考测量程序的一致性总体满意,但一种常规检测显示显著偏倚。
核心结论
- 高浓度加标混合血浆样本和加标个体血浆样本是去甲变肾上腺素和变肾上腺素检测的候选外部质量评估材料。
研究设计与样本
- 用四种常规同位素稀释串联质谱法和候选参考测量程序检测所有样本。
- 基于CLSI和IFCC推荐的两种方法评估互换性,并用Passing-Bablok回归和Bland-Altman分析评价一致性。
主要发现
- CLSI方法的互换性结果优于IFCC方法。
- 按CLSI方法,加标个体血浆和加标高浓度混合血浆对两种分析物的所有常规检测均具有互换性。
- 未加标混合血浆对变肾上腺素四种常规检测中的两种具有互换性,对去甲变肾上腺素四种常规检测中的三种具有互换性。
- 常规检测与候选参考测量程序的一致性总体满意,但一种常规检测显示显著偏倚。
临床怎么用
- 建议将高浓度加标混合血浆和加标个体血浆作为去甲变肾上腺素和变肾上腺素外部质量评估的候选材料。
- 常规检测与参考程序的一致性总体满意,但需关注一种常规检测的显著偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To identify candidate external quality assessment (EQA) materials for normetanephrine and metanephrine measurements, we assessed the commutability of eight processed human plasma samples. The agreement between routine assays and the candidate reference measurement procedure (cRMP) was also evaluated. METHODS: Fifty-three clinical samples and eight processed plasma samples were prepared. The processed samples included pooled and individual plasma samples spiked with pure normetanephrine and metanephrine and non-spiked pooled and individual plasma samples. The clinical and processed samples were subjected to four routine isotope dilution tandem mass spectrometry assays and cRMP. Commutability was assessed based on two approaches recommended by the CLSI and International Federation of Clinical Chemistry (IFCC). Passing-Bablok regression and Bland-Altman analysis were used to evaluate the agreement between the routine assays and cRMP. RESULTS: The commutability results of the CLSI approach were better than those of the IFCC approach. For the CLSI approach, spiked individual plasma samples and spiked high-concentration pooled plasma samples were commutable for all routine assays for both analytes. The non-spiked pooled plasma sample was commutable for two out of four routine assays for metanephrine and three out of four routine assays for normetanephrine. The agreement between the routine assays and the cRMP was satisfactory, except for one routine assay showing significant bias. CONCLUSIONS: High-concentration spiked pooled plasma samples and spiked individual plasma samples are candidate EQA materials for normetanephrine and metanephrine measurements.
引用
- Deng Y, Liu Q, Liu Z, et al. Commutability Assessment of Processed Human Plasma Samples for Normetanephrine and Metanephrine Measurements Based on the Candidate Reference Measurement Procedure. Ann Lab Med. 2022. PMID: 35470275. doi:10.3343/alm.2022.42.5.575
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。